-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SE7EgFA+RWwkn0bd3MM9LHx4Mic1jFk+ClUXktMRGvnyVpROzW8yFS7upYJWq58q crcyCDq9aqSnoNOOIy831g== 0001193125-09-173109.txt : 20090812 0001193125-09-173109.hdr.sgml : 20090812 20090812170346 ACCESSION NUMBER: 0001193125-09-173109 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090812 DATE AS OF CHANGE: 20090812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Abraxis Health, Inc. CENTRAL INDEX KEY: 0001452016 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 000-53568 FILM NUMBER: 091007550 BUSINESS ADDRESS: STREET 1: 11755 WILSHIRE BOULEVARD, SUITE 2000 CITY: LOS ANGELES STATE: CA ZIP: 90025 BUSINESS PHONE: (310) 883-1300 MAIL ADDRESS: STREET 1: 11755 WILSHIRE BOULEVARD, SUITE 2000 CITY: LOS ANGELES STATE: CA ZIP: 90025 RW 1 drw.htm WITHDRAWAL OF REGISTRATION STATEMENT ON FORM 10-12G Withdrawal of Registration Statement on Form 10-12G

ABRAXIS HEALTH, INC.

11755 Wilshire Boulevard, Suite 2000

Los Angeles, California 90025

August 12, 2009

By EDGAR and Facsimile

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, D.C. 20549

Attention: Jeffrey P. Riedler

 

Re: Abraxis Health, Inc.
     Registration Statement on Form 10-12G (File No. 000-53568)
     Application for Withdrawal

Ladies and Gentlemen:

Abraxis Health, Inc. (the “Company”) hereby withdraws the above-referenced Registration Statement. The Registration Statement was originally filed with the Securities and Exchange Commission (the “Commission”) on January 21, 2009, withdrawn and re-filed on June 15, 2009 and most recently amended on August 4, 2009. The Registration Statement has not yet been completed.

The Company is withdrawing the Registration Statement to prevent it from becoming effective prior to completion under the automatic effectiveness provisions of Section 12(g)(1) of the Securities Exchange Act of 1934, as amended. As discussed with the Commission staff, the Company intends shortly to file a new Form 10 registration statement.

 

Sincerely,
/s/ Patrick Soon-Shiong, M.D.

Patrick Soon-Shiong, M.D.

Chief Executive Officer

 

cc: Nandini Acharya—Securities and Exchange Commission
-----END PRIVACY-ENHANCED MESSAGE-----